期刊文献+

盆腔淋巴结清扫对评估膀胱癌预后的价值 被引量:2

Prognostic significance of pelvic lymphadenectomy in patients with bladder cancer
下载PDF
导出
摘要 目的:评价规范化盆腔淋巴结清扫对膀胱癌患者预后的影响作用,分析影响淋巴结转移的相关因素及淋巴结肿大与淋巴结转移两者的关系。方法:回顾性分析2008年1月至2013年7月天津医科大学肿瘤医院120例膀胱癌患者临床资料,分为盆腔淋巴结规范化清扫组58例,未规范化清扫组62例。分析淋巴结转移与病理分期、分级及术中触及肿大淋巴结的关系,探讨盆腔淋巴结清扫对预后的影响。结果:120例膀胱癌患者术后1、3、5年总生存率分别为84.0%、69.9%、57.9%。规范化盆腔淋巴结清扫组与未规范化清扫组的3年生存率分别为78.4%与46.2%(χ2=5.487,P=0.019)。淋巴结阳性与阴性患者术后3年生存率分别为50.0%与86.4%,(χ2=9.303,P=0.002)。术中触及肿大淋巴结与淋巴结转移具有相关性(P<0.001),病理分期、病理类型(尿路上皮癌及非尿路上皮癌)及年龄是患者预后的影响因素(P<0.05)。结论:术中触及肿大淋巴结与淋巴结转移相关,可预测淋巴结转移的发生,盆腔淋巴结清扫影响膀胱癌患者预后,阳性淋巴结是膀胱癌患者预后的独立危险因素,规范盆腔淋巴结清扫术可延长患者术后生存时间。 Objective:To evaluate the prognostic significance of standard pelvic lymphadenectomy on the disease-free survival (DFS) rate of bladder cancer patients undergoing radical cystectomy (RC) and to discuss the influencing factors of lymph node positivity and the relationship between positive lymph nodes and lymphadenectasis. Methods:This prospective analysis includes 120 cases of bladder cancer treated with pelvic lymphadenectomy and RC in Tianjin Medical University Cancer Institute and Hospital between 2008 and 2013. The cases were divided into two groups, namely, the standard pelvic lymphadenectomy group (Group A) and the nonstandard pelvic lymphadenectomy group (Group B). The relationships among positive lymph nodes, lymphadenectasis, tumor stage, and patho-logical grade were retrospectively analyzed. Results:The 1-, 3-, and 5-year overall survival rates of 120 patients were 84%, 69.9%, and 57.9%, respectively. Group A was significantly correlated with a better 3-year overall survival rate than Group B, i.e., 78.4%vs. 46.2%(P〈0.05). Lymphadenectasis influenced the DFS rate of bladder cancer patients after RC with pelvic lymphadenectomy, i.e., 50.0%vs. 86.4%(χ^2=9.303, P〈0.05). Meanwhile, lymphadenectasis was positively correlated with lymph node positivity (P〈0.001). Tumor stage, histological subtype (urothelial carcinoma and non-urothelial carcinoma), and age were the prognostic factors for bladder cancer (P〈0.05). Conclusion:Intraoperative lymphadenectasis is the influencing factor of lymph node positivity. This study determined that standard pel-vic lymphadenectomy and lymphadenectasis may influence the DFS rate after RC and are the independent risk factors for the prognosis of bladder cancer. Creating evidence-based guidelines of standardized lymphadenectomy for further improvement of the surgical quali-ty and survival of bladder cancer patients is essential.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2015年第17期866-870,共5页 Chinese Journal of Clinical Oncology
关键词 膀胱肿瘤 全膀胱切除术 淋巴结清扫术 淋巴结阳性 urinary bladder neoplasm cystectomy lymph node excision lymph node positivity
  • 相关文献

参考文献16

  • 1Siegel R, MaJ, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1):9-29.
  • 2Witjes JA, Compctrat E, Gowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines[J]. Eur Urol, 2014, 65(4):778-792.
  • 3Tilki D, Brausi M, Colombo R, et al. Lymphadenectomy for blad- der cancer at the time of radical cystectomy~. Eur Urol, 2013, 64 (2) :266-276.
  • 4Shariat SF, Ehdaie B, Rink M, et al. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment[J]. Eur Urol, 2012, 61(2):237-242.
  • 5May M, Herrmann E, Bolenz C, et al. Association between the number of dissected lymph nodes during pelvic lymphadenecto- my and cancer-specific survival in patients with lymph node- negative urothelial carcinoma of the bladder undergoing radical cystectomy[J]. Ann Surg Oncol, 2011, 18(7):2018-2025.
  • 6Zehnder P, Thalmann GN. Timing and outcomes for radical cys- tectomy in nonmuscle invasive bladder cancer[J]. Curr Opin Urol, 2013, 23 (5) :423-428.
  • 7Morgan TM, Kaffenberger SD, Cookson MS. Surgical and che- motherapeutic management of regional lymph nodes in bladder canccr[J]. Urol, 2012, 188(4):1081-1088.
  • 8Ugurlu O, Baltaci S, Asian G, et al. Does skip metastasis or other lymph node parameters have additional effects on survival of pa- tients undergoing radical cystectomy for bladder cancer[J]? Kore- anJ Urol, 2015, 56(5):357-364.
  • 9Burkhard FC, Roth B, Zehnder P, et al. Lymphadenectomy for bladder cancer: indications and controversies[J]. Urol Clin North Am, 2011, 38 (4) :397-405.
  • 10KuJH, Kang M, Kim HS, et al. Lymph node density as a prog-nostic variable in node-positive bladder cancer: a meta-analysis [J]. BMC Cancer, 2015, 15:447.

同被引文献31

  • 1李斌,李树斌,李俊杰.阳性淋巴结比率对胸腔镜下手术治疗食管癌患者生存状况的影响[J].医药论坛杂志,2021,42(13):39-43. 被引量:1
  • 2BABJUK M, OOSTERLINCK W, SYLVESTER R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder,the 2011 update[J]. Eur Urol,2011,59(6):997 1008.
  • 3LUCCA I, ROUPRET M, KLUTH I., et al. Adjuvant cisplatin based combined chemotherapy for lymph node (LN)positive urothelial carcinoma of the bladder(UCB) after radical cystecto- my(RC) :a retrospective international study ofgt:1500 patients [J]. BJU Int,2015,115(5) :722 727.
  • 4BURKHARD FC, ROTH B, ZEHNDER P, et al. Lymphadenec tomy for bladder cancer: indications and controeersies[J]. Urol Clin North Am,2011,38(4):397 405.
  • 5HERMANS TJ,FOSSION LM. Oncologie outcome after laparo- scopic radical cystectomy without neoadjuvant or adjuvant thera- py with a median follow up of 32 months[J]. Urol Int,2014,92(1):55-63.
  • 6STUD1 D, SVATEK RS, NIEI.SEN ME, et al. Extent of pelvic lymph node dissectionduring radical cystectomy:is bigger better? [J]. Rev Urol,2014,16(4) : 159-166.
  • 7BI L, HUANG H, FAN X, et al. Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free sur vival in patients undergoing radical cystectomy for bladder canc er:a systematic review and meta-analysis of comparative studies [J]. BJU Int,2014,113(5b):E39-48.
  • 8HUANG J, I.IN T, LIU H, et al. Laparoseopic radical cystectomy with orthotopie ileal neobladder for bladder cancer: oncologic re suits of 171 cases with a median 3-year follow up[J]. Eur Urol, 2010,58(3) :442-449.
  • 9FRANKI O, NARDUCCI F, CHEREAU-EWALD E, et al. Role of a double docking to improve lymph node dissection: when ro botieally assisted laparoseopy for para-aoetie lymphadeneetomy is associated to a pelvic procedure[J]. Int J Gyneeol Canee, 2015,25 (2):331 336.
  • 10GANDAGLIA G, SUARDI N, GALLINA A, et al. Extended pel vic lymph node dissection does not affect erectile function reeov cry in patients treated with bilateral nerve-sparing radical prosta tectomy[J]. J Sex Med,2012,9(8) :2187-2194.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部